AAAAAA

   
Results: 1-25 | 26-50 | 51-60
Results: 1-25/60
NO EFFECT OF MIGLITOL ON THE ORAL BIOAVAILABILITY OF SINGLE-DOSE PHENYTOIN IN HEALTHY-MALES
Authors: RICHARDT D ROSMARIN C HAVLIK I SCHALL R
Citation: D. Richardt et al., NO EFFECT OF MIGLITOL ON THE ORAL BIOAVAILABILITY OF SINGLE-DOSE PHENYTOIN IN HEALTHY-MALES, Clinical drug investigation, 13(3), 1997, pp. 171-174
THE EARLY BACTERICIDAL ACTIVITY OF CIPROFLOXACIN IN PATIENTS WITH PULMONARY TUBERCULOSIS
Authors: SIRGEL FA BOTHA FJ PARKIN DP VANDEWAL BW SCHALL R DONALD PR MITCHISON DA
Citation: Fa. Sirgel et al., THE EARLY BACTERICIDAL ACTIVITY OF CIPROFLOXACIN IN PATIENTS WITH PULMONARY TUBERCULOSIS, American journal of respiratory and critical care medicine, 156(3), 1997, pp. 901-905
INDIVIDUAL BIOEQUIVALENCE - NEW CONCEPTS IN THE STATISTICAL ASSESSMENT OF BIOEQUIVALENCE METRICS
Authors: PATNAIK RN LESKO LJ CHEN ML WILIAMS RL BALCH A CHAN K MACHADO S SCHUIRMANN D HAUCK W SCHALL R
Citation: Rn. Patnaik et al., INDIVIDUAL BIOEQUIVALENCE - NEW CONCEPTS IN THE STATISTICAL ASSESSMENT OF BIOEQUIVALENCE METRICS, Clinical pharmacokinetics, 33(1), 1997, pp. 1-6
BIOEQUIVALENCE OF CONTROLLED-RELEASE CALCIUM-ANTAGONISTS
Authors: SCHALL R MULLER FR MULLER FO LUUS HG
Citation: R. Schall et al., BIOEQUIVALENCE OF CONTROLLED-RELEASE CALCIUM-ANTAGONISTS, Clinical pharmacokinetics, 32(1), 1997, pp. 75-89
PHARMACOKINETICS OF TRIPTORELIN AFTER INTRAVENOUS BOLUS ADMINISTRATION IN HEALTHY-MALES AND IN MALES WITH RENAL OR HEPATIC INSUFFICIENCY
Authors: MULLER FO TERBLANCHE J SCHALL R SMIT RV TUCKER T MARAIS K GROENEWOUD G PORCHET HC WEINER M HAWARDEN D
Citation: Fo. Muller et al., PHARMACOKINETICS OF TRIPTORELIN AFTER INTRAVENOUS BOLUS ADMINISTRATION IN HEALTHY-MALES AND IN MALES WITH RENAL OR HEPATIC INSUFFICIENCY, British journal of clinical pharmacology, 44(4), 1997, pp. 335-341
AN EVALUATION OF THE INTERACTION OF MELOXICAM WITH FRUSEMIDE IN PATIENTS WITH COMPENSATED CHRONIC CARDIAC-FAILURE
Authors: MULLER FO MIDDLE MV SCHALL R TERBLANCHE J HUNDT HKL GROENEWOUD G
Citation: Fo. Muller et al., AN EVALUATION OF THE INTERACTION OF MELOXICAM WITH FRUSEMIDE IN PATIENTS WITH COMPENSATED CHRONIC CARDIAC-FAILURE, British journal of clinical pharmacology, 44(4), 1997, pp. 393-398
ICPM-INDEPENDENT COMPUTER-ASSISTED DOCUME NTATION CONCERNING THE NEW LAW ON STATE CARE BENEFITS - METHODS AND RESULTS IN 1995
Authors: HUBER FX SCHALL R FRITZKRIEGLSTEIN C GLEIM U HERFARTH C
Citation: Fx. Huber et al., ICPM-INDEPENDENT COMPUTER-ASSISTED DOCUME NTATION CONCERNING THE NEW LAW ON STATE CARE BENEFITS - METHODS AND RESULTS IN 1995, Langenbecks Archiv fur Chirurgie, 382(2), 1997, pp. 69-73
NO INTERACTION BETWEEN MELOXICAM AND FUROSEMIDE IN CARDIAC-FAILURE
Authors: MULLER FO MIDDLE MV SCHALL R TERBLANCHE J HUNDT HKL GROENEWOUD G
Citation: Fo. Muller et al., NO INTERACTION BETWEEN MELOXICAM AND FUROSEMIDE IN CARDIAC-FAILURE, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 100-100
ASSESSMENT OF INDIVIDUAL AND POPULATION BIOEQUIVALENCE USING THE PROBABILITY THAT BIOAVAILABILITIES ARE SIMILAR - REPLY
Authors: SCHALL R
Citation: R. Schall, ASSESSMENT OF INDIVIDUAL AND POPULATION BIOEQUIVALENCE USING THE PROBABILITY THAT BIOAVAILABILITIES ARE SIMILAR - REPLY, Biometrics, 53(1), 1997, pp. 383-384
EFFECT OF IPSAPIRONE ON PLASMA-GLUCOSE AND PHARMACOKINETICS OF IPSAPIRONE IN TYPE-I DIABETICS
Authors: LUUS HG MULLER FO GROENEWOUD G HUNDT HKL SCHALL R VANDYK M
Citation: Hg. Luus et al., EFFECT OF IPSAPIRONE ON PLASMA-GLUCOSE AND PHARMACOKINETICS OF IPSAPIRONE IN TYPE-I DIABETICS, Clinical drug investigation, 11(3), 1996, pp. 159-166
NO INFLUENCE OF PANTOPRAZOLE ON THE PHARMACOKINETICS OF PHENYTOIN
Authors: MIDDLE MV MULLER FO SCHALL R GROENEWOUD G HUNDT HKL HUBER R BLIESATH H STEINIJANS VW
Citation: Mv. Middle et al., NO INFLUENCE OF PANTOPRAZOLE ON THE PHARMACOKINETICS OF PHENYTOIN, International journal of clinical pharmacology and therapeutics, 34, 1996, pp. 72-75
THE EFFICACY OF 2 BUPIVACAINE HYDROCHLORIDE INJECTION PRODUCTS
Authors: MULLER FO CLAASEN JP SCHALL R MOGILNICKA EM VOS JD GROENEWOUD G MIDDLE MV STULTING AA
Citation: Fo. Muller et al., THE EFFICACY OF 2 BUPIVACAINE HYDROCHLORIDE INJECTION PRODUCTS, South African medical journal, 86(6), 1996, pp. 667-669
CLINICAL-EXPERIENCE WITH REPOTIN, A LOCALLY PRODUCED RECOMBINANT-HUMAN-ERYTHROPOIETIN, IN THE TREATMENT OF ANEMIA OF CHRONIC-RENAL-FAILURE IN SOUTH-AFRICA
Authors: SWANEPOEL CR MOOSA MR ROWLAND GF MEYERS AM BOTHA BP SMART AJ GOODMAN R SCHALL R KEOGH HJ MERRIFIELD EH
Citation: Cr. Swanepoel et al., CLINICAL-EXPERIENCE WITH REPOTIN, A LOCALLY PRODUCED RECOMBINANT-HUMAN-ERYTHROPOIETIN, IN THE TREATMENT OF ANEMIA OF CHRONIC-RENAL-FAILURE IN SOUTH-AFRICA, South African medical journal, 86(10), 1996, pp. 1266-1269
RELATIVE BIOAVAILABILITY OF 4 CLOMIPRAMINE HYDROCHLORIDE TABLET PRODUCTS
Authors: MULLER FO SCHALL R MOGILNICKA EM GROENEWOUD G HUNDT HKL LUUS HG MIDDLE MV SWART KJ DEVAAL AC
Citation: Fo. Muller et al., RELATIVE BIOAVAILABILITY OF 4 CLOMIPRAMINE HYDROCHLORIDE TABLET PRODUCTS, Biopharmaceutics & drug disposition, 17(1), 1996, pp. 81-90
TOWARDS A PRACTICAL STRATEGY FOR ASSESSING INDIVIDUAL BIOEQUIVALENCE
Authors: SCHALL R WILLIAMS RL
Citation: R. Schall et Rl. Williams, TOWARDS A PRACTICAL STRATEGY FOR ASSESSING INDIVIDUAL BIOEQUIVALENCE, Journal of pharmacokinetics and biopharmaceutics, 24(1), 1996, pp. 133-149
1995 - DID THE GSG EMBRACE THE OPERATIVE FOCUS OF UNIVERSITY CLINICS
Authors: HUBER FX SCHALL R FRITZ C HERFARTH C
Citation: Fx. Huber et al., 1995 - DID THE GSG EMBRACE THE OPERATIVE FOCUS OF UNIVERSITY CLINICS, Langenbecks Archiv fur Chirurgie, 1996, pp. 1299-1300
BIOAVAILABILITY OF 2 SELEGILINE HYDROCHLORIDE TABLET PRODUCTS
Authors: MULLER FO SCHALL R HUNDT HKL JOUBERT A MIDDLE MV MUIR AR DUURSEMA L GROENEWOUD G SWART KJ
Citation: Fo. Muller et al., BIOAVAILABILITY OF 2 SELEGILINE HYDROCHLORIDE TABLET PRODUCTS, Arzneimittel-Forschung, 46(11), 1996, pp. 1037-1040
STUDY OF THE EFFECT OF MIGLITOL ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN IN HEALTHY-MALES
Authors: SCHALL R MULLER FO HUNDT HKL DUURSEMA L GROENEWOUD G MIDDLE MV
Citation: R. Schall et al., STUDY OF THE EFFECT OF MIGLITOL ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN IN HEALTHY-MALES, Arzneimittel-Forschung, 46(1), 1996, pp. 41-46
EFFECT OF PANTOPRAZOLE ON OVULATION SUPPRESSION BY A LOW-DOSE HORMONAL CONTRACEPTIVE
Authors: MIDDLE MV MULLER FO SCHALL R HUNDT HKL MOGILNICKA EM BENEKE PC
Citation: Mv. Middle et al., EFFECT OF PANTOPRAZOLE ON OVULATION SUPPRESSION BY A LOW-DOSE HORMONAL CONTRACEPTIVE, Clinical drug investigation, 9(1), 1995, pp. 54-56
REFERENCE TABLES FOR THE INTRASUBJECT COEFFICIENT OF VARIATION IN BIOEQUIVALENCE STUDIES
Authors: STEINIJANS VW SAUTER R HAUSCHKE D DILETTI E SCHALL R LUUS HG ELZE M BLUME H HOFFMANN C FRANKE G SIEGMUND W
Citation: Vw. Steinijans et al., REFERENCE TABLES FOR THE INTRASUBJECT COEFFICIENT OF VARIATION IN BIOEQUIVALENCE STUDIES, International journal of clinical pharmacology and therapeutics, 33(8), 1995, pp. 427-430
NO INFLUENCE OF PANTOPRAZOLE ON THE PHARMACOKINETICS OF PHENYTOIN
Authors: MIDDLE MV MULLER FO SCHALL R GROENEWOUD G HUNDT HKL HUBER R BLIESATH H STEINIJANS VW
Citation: Mv. Middle et al., NO INFLUENCE OF PANTOPRAZOLE ON THE PHARMACOKINETICS OF PHENYTOIN, International journal of clinical pharmacology and therapeutics, 33(5), 1995, pp. 304-307
LACK OF EFFECT OF PANTOPRAZOLE ON THE PHARMACODYNAMICS AND PHARMACOKINETICS OF WARFARIN
Authors: DUURSEMA L MULLER FO SCHALL R MIDDLE MV HUNDT HKL GROENEWOUD G STEINIJANS VW BLIESATH H
Citation: L. Duursema et al., LACK OF EFFECT OF PANTOPRAZOLE ON THE PHARMACODYNAMICS AND PHARMACOKINETICS OF WARFARIN, British journal of clinical pharmacology, 39(6), 1995, pp. 700-703
THE EFFECT OF FASTING ON TOTAL SERUM BILIRUBIN CONCENTRATIONS
Authors: MEYER BH SCHOLTZ HE SCHALL R MULLER FO HUNDT HKL MAREE JS
Citation: Bh. Meyer et al., THE EFFECT OF FASTING ON TOTAL SERUM BILIRUBIN CONCENTRATIONS, British journal of clinical pharmacology, 39(2), 1995, pp. 169-171
MOCLOBEMIDE TWICE-DAILY IN THE TREATMENT OF MAJOR DEPRESSIVE EPISODE - A DOUBLE-BLIND, MULTICENTER COMPARISON WITH DIFFERENT 3 TIMES DAILY DOSAGE SCHEDULES
Authors: GAGIANO CA MULLER FGM BERK M JOUBERT PM BROWN RGCW SCHALL R
Citation: Ca. Gagiano et al., MOCLOBEMIDE TWICE-DAILY IN THE TREATMENT OF MAJOR DEPRESSIVE EPISODE - A DOUBLE-BLIND, MULTICENTER COMPARISON WITH DIFFERENT 3 TIMES DAILY DOSAGE SCHEDULES, Journal of clinical psychopharmacology, 15(4), 1995, pp. 4-9
MOCLOBEMIDE IN CONTINUATION TREATMENT OF MAJOR DEPRESSIVE EPISODES - AN OPEN FOLLOW-UP-STUDY OVER 6 MONTHS
Authors: GAGIANO CA MULLER FGM DEKOCK RF SCHALL R
Citation: Ca. Gagiano et al., MOCLOBEMIDE IN CONTINUATION TREATMENT OF MAJOR DEPRESSIVE EPISODES - AN OPEN FOLLOW-UP-STUDY OVER 6 MONTHS, Journal of clinical psychopharmacology, 15(4), 1995, pp. 46-50
Risultati: 1-25 | 26-50 | 51-60